Scopus BioPharma Inc.
SCPS
$0.0003
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 21.18% | 47.44% | 73.45% | -35.59% | 78.76% |
| Total Depreciation and Amortization | -50.00% | -66.67% | -50.00% | -25.00% | 50.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -346.53% | -259.68% | -103.01% | 106.35% | -99.25% |
| Change in Net Operating Assets | 428.47% | 213.39% | -35.85% | 757.61% | -27.69% |
| Cash from Operations | 64.90% | 80.90% | 89.83% | 66.16% | -46.53% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 119.05% | -- | -- |
| Cash from Financing | -- | -- | -97.15% | -- | -- |
| Foreign Exchange rate Adjustments | -74.65% | 58.72% | 69.57% | 205.26% | 533.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.12% | 132.18% | -104.32% | 67.84% | -41.29% |